The Treatment of Moderately Advanced Carcinoma with Chemo-Immunotherapy / 中国肿瘤生物治疗杂志
Chinese Journal of Cancer Biotherapy
; (6)1996.
Article
in Zh
| WPRIM
| ID: wpr-581737
Responsible library:
WPRO
ABSTRACT
A comparison of effectiveness of chemo-immunotherapy (CIT) using LAK/CD3AK 1-2 weeks after TACE in 74 patients with no surgical indication and TACE alone in 41 patients with moderately advanced HCC was carried out. The rates of remission between CIT group and TACE alone group were 72.4% and 40.4%(P
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Cancer Biotherapy
Year:
1996
Type:
Article